Immune checkpoint inhibitors for advanced pancreatic cancer
Wei Yen Chan(The University of Sydney), Venessa Chin(Garvan Institute of Medical Research), Muhammad Abdi Haryono(University Medical Center Utrecht), Desmond Yip(Calvary Hospital), Hao‐Wen Sim(The University of Sydney)
Cited by 1
Related Papers
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
|European Journal of Cancer|2015|337
Changes in plasma biochemistry in horses competing in a 160 km endurance ride
|Australian Veterinary Journal|1983|60
A systematic review of surgical ablation versus catheter ablation for atrial fibrillation.
|PubMed|2013|54
PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
|Cancers|2021|28
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
|Journal of Experimental & Clinical Cancer Research|2024|22